According to a USADA press release UFC bantamweight Khalid Taha (14-2) has accepted a one-year suspension in relation to an in-competition drug test failure. He tested positive for Furosemide, which is included on USADA’s list of banned diuretics and masking agents.
Taha has claimed that the drug test failure is a result of medication he took because of a problem with his eyes (per germanfightnews.com).
The urine sample that contained Furosemide was provided by Taha at UFC 243, in Melbourne’s Marvel Stadium, on October 6th. That night Taha beat Bruno Gustavo da Silva by submission for his second win the in the UFC.